A Phase ll Trial of Induction Docetaxel and S-1 Followed by Concomitant Radiotherapy With Low-dose Daily Cisplatin in Locally Advanced Head and Neck Cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 19 Mar 2008 New trial record.